Skip to main content
Clinical Trials/NCT04084340
NCT04084340CompletedPhase 2

Efficacy of Transcranial Direct Current Stimulation Combined With Exercise Therapies in Female Urinary Incontinence: a Randomized Clinical Trial

Universidade Federal do Piauí2 sites in 1 country60 target enrollmentStarted: November 14, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
60
Locations
2
Primary Endpoint
Urinary leakage

Study Overview

Brief Summary

Urinary incontinence (UI) is defined as any involuntary loss of urine and can be divided into three types: urgency, stress and mixed. Pelvic floor exercises are considered the main non pharmacological choice for UI treatment. Its mechanisms are not fully understood, however there are some evidence that central mechanisms play an important role in the continence control. In this context, neuromodulatory techniques, such as transcranial direct current stimulation (tDCS), that address cortical targets has been demonstrated promising results in different health conditions. However, few studies have investigated the efficacy of adding tDCS to exercise therapies for women with UI.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Complaining of urinary loss
  • •Seeking care for urinary incontinence

Exclusion Criteria

  • •Grade III vaginal dystopias
  • •Intrapelvic tumors
  • •Cardiac pacemaker or other implanted devices
  • •Current pregnancy
  • •Urinary tract infections
  • •Previous treatment with tDCS

Arms & Interventions

Anodal tDCS + Exercises therapies

Experimental

Real transcranial direct current stimulation associated with therapeutic exercises

tDCS: 20 minutes, 2mA

Intervention: Real transcranial direct current stimulation + therapeutic exercises for urinary incontinence (Procedure)

Sham tDCS + Exercises therapies

Sham Comparator

Sham transcranial direct current stimulation associated with therapeutic exercises

tDCS: 20 minutes (30 seconds ON), 2mA

Intervention: Sham transcranial direct current stimulation + therapeutic exercises for urinary incontinence (Procedure)

Outcomes

Primary Outcomes

Urinary leakage

Time Frame: 4 weeks after randomization

Urinary leakage will be measured by the pad test. Pad testing yields an objective measurement of fluid loss over a certain period. The outcome of the 1-h pad test will be recorded as the weight gain as measured by a verified spring balance. Pad test assessment: Change in 1-hour exercise (stress), classified as mild, moderate or severe urinary leaking.

Incontinence severity

Time Frame: 4 weeks after randomization

Incontinence severity will be assessed by the Brazilian version of Incontinence severity index (ISI) that quantifies the frequency and number of urinary leaking. The ISI comprehend two questions about quantity and frequency of urinary losses. The score are from 0 to 12: 0 continent 1 or 2 mild incontinence 3 or 6 moderate incontinence 8 or 9 severe incontinence 12 very severe incontinence

Quality of life impact

Time Frame: 4 weeks after randomization

Quality of life impact of urinary incontinence will be assessed by the Brazilian Version of International consultation on incontinence questionnaire urinary incontinence (ICIQ_UI short form). The ICIQ-UI Short form provides a score ranging from 0-21. With a higher score indicating greater severity of symptoms.

Secondary Outcomes

  • Pelvic floor muscle strength - Subjective test(4 weeks, 3 and 6 months after randomization)
  • Quality of life in women with UI (severity symptoms)(4 weeks, 3 and 6 months after randomization)
  • Incontinence severity(3 and 6 months after randomization ])
  • Global perceived effect (GPE)(4 weeks, 3 and 6 months after randomization)
  • Quality of life impact(3 and 6 months after randomization ])
  • Urinary leaking(4 weeks, 3 and 6 months after randomization)
  • Pelvic floor muscle strength - Quantitative test(4 weeks, 3 and 6 months after randomization)
  • Urinary leakage(3 and 6 months after randomization)
  • Emotional impact(4 weeks, 3 and 6 months after randomization)

Investigators

Sponsor
Universidade Federal do Piauí
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Fuad Ahmad Hazime

Clinical Professor - Physical Therapy Department

Universidade Federal do Piauí

Study Sites (2)

Loading locations...

Similar Trials